Yeon‐Hee Baek

407 total citations
24 papers, 256 citations indexed

About

Yeon‐Hee Baek is a scholar working on Geriatrics and Gerontology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yeon‐Hee Baek has authored 24 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yeon‐Hee Baek's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Bone health and treatments (5 papers). Yeon‐Hee Baek is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Bone health and treatments (5 papers). Yeon‐Hee Baek collaborates with scholars based in South Korea, United States and Australia. Yeon‐Hee Baek's co-authors include Ju‐Young Shin, Ju Hwan Kim, Jeehye Park, Lisa Kalisch Ellett, Nicole Pratt, Hyesung Lee, Ha‐Lim Jeon, Han Eol Jeong, Hye Jun Kim and Soojung Hong and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and International Journal of Epidemiology.

In The Last Decade

Yeon‐Hee Baek

23 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yeon‐Hee Baek South Korea 11 59 47 46 42 30 24 256
Leila Chebane France 11 21 0.4× 42 0.9× 27 0.6× 67 1.6× 34 1.1× 26 285
María Sáinz-Gil Spain 11 31 0.5× 18 0.4× 91 2.0× 37 0.9× 68 2.3× 49 436
Li‐Na Kuo Taiwan 10 41 0.7× 40 0.9× 23 0.5× 19 0.5× 20 0.7× 24 342
Jennifer Corny France 10 37 0.6× 81 1.7× 15 0.3× 20 0.5× 28 0.9× 23 303
Justine Bénevent France 11 14 0.2× 25 0.5× 16 0.3× 45 1.1× 45 1.5× 36 312
William Wang United States 10 47 0.8× 17 0.4× 61 1.3× 13 0.3× 21 0.7× 19 460
Fanny Rocher France 12 108 1.8× 12 0.3× 29 0.6× 78 1.9× 36 1.2× 58 547
Mê‐Linh Lê Canada 10 22 0.4× 23 0.5× 69 1.5× 15 0.4× 16 0.5× 38 395
Ha‐Lim Jeon South Korea 9 53 0.9× 32 0.7× 26 0.6× 5 0.1× 19 0.6× 31 265
H. Karl Greenblatt United States 8 19 0.3× 10 0.2× 45 1.0× 25 0.6× 30 1.0× 10 231

Countries citing papers authored by Yeon‐Hee Baek

Since Specialization
Citations

This map shows the geographic impact of Yeon‐Hee Baek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeon‐Hee Baek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeon‐Hee Baek more than expected).

Fields of papers citing papers by Yeon‐Hee Baek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeon‐Hee Baek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeon‐Hee Baek. The network helps show where Yeon‐Hee Baek may publish in the future.

Co-authorship network of co-authors of Yeon‐Hee Baek

This figure shows the co-authorship network connecting the top 25 collaborators of Yeon‐Hee Baek. A scholar is included among the top collaborators of Yeon‐Hee Baek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeon‐Hee Baek. Yeon‐Hee Baek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ah‐Ram, Yeon‐Hee Baek, Hee Jun Kang, et al.. (2025). Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD. Cardiology and Therapy. 14(1). 101–115.
2.
Lee, Hyesung, Yeon‐Hee Baek, Ju Hwan Kim, et al.. (2023). Trends of polypharmacy among older people in Asia, Australia and the United Kingdom: a multinational population-based study. Age and Ageing. 52(2). 14 indexed citations
3.
Baek, Yeon‐Hee, Yunha Noh, Han Eol Jeong, et al.. (2022). Analytical Approaches to Reduce Selection Bias in As-Treated Analyses with Missing In-Hospital Drug Information. Drug Safety. 45(10). 1057–1067. 1 indexed citations
4.
Au, Philip Chun-Ming, Yeon‐Hee Baek, Ching‐Lung Cheung, et al.. (2022). Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study. BioDrugs. 36(3). 381–392. 4 indexed citations
5.
Kim, Ju Hwan, Philip Chun-Ming Au, Yeon‐Hee Baek, et al.. (2022). Bone-targeting agents in major solid tumour metastases: a multinational cohort study. BMJ Supportive & Palliative Care. 13(e3). e1064–e1073. 1 indexed citations
6.
Kim, Ju Hwan, et al.. (2021). Treatment pattern in postmenopausal women with osteoporosis: a population-based cohort study in South Korea. Journal of Bone and Mineral Metabolism. 40(1). 109–119. 3 indexed citations
7.
Baek, Yeon‐Hee, Sun Wook Cho, Han Eol Jeong, et al.. (2021). 10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea. Endocrinology and Metabolism. 36(6). 1178–1188. 15 indexed citations
8.
Baek, Yeon‐Hee, et al.. (2021). Machine Learning for Detection of Safety Signals From Spontaneous Reporting System Data: Example of Nivolumab and Docetaxel. Frontiers in Pharmacology. 11. 602365–602365. 18 indexed citations
9.
Baek, Yeon‐Hee, Eun Joo Kang, Soojung Hong, et al.. (2021). Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors. International Journal of Cancer. 150(8). 1291–1300. 18 indexed citations
10.
Kim, Ju Hwan, Yeon‐Hee Baek, Hyesung Lee, et al.. (2020). Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study. Epidemiology and Health. 43. e2021004–e2021004. 11 indexed citations
11.
Baek, Yeon‐Hee, et al.. (2020). Benzodiazepine-Related Cognitive Impairment or Dementia: A Signal Detection Study Using a Case/Non-Case Approach. Psychiatry Investigation. 17(6). 587–595. 10 indexed citations
12.
13.
Kim, Hye Jun, et al.. (2019). Characteristics and trends of spontaneous reporting of therapeutic ineffectiveness in South Korea from 2000 to 2016. PLoS ONE. 14(2). e0212905–e0212905. 7 indexed citations
14.
Jeon, Ha‐Lim, et al.. (2019). Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma. Journal of Bone and Mineral Metabolism. 38(2). 254–263. 13 indexed citations
15.
16.
Baek, Yeon‐Hee, Hyesung Lee, Woo Jung Kim, et al.. (2019). Uncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study. Journal of the American Medical Directors Association. 21(2). 201–211.e2. 21 indexed citations
17.
Baek, Yeon‐Hee & Ju‐Young Shin. (2018). Trends in polypharmacy over 12 years and changes in its social gradients in South Korea. PLoS ONE. 13(9). e0204018–e0204018. 15 indexed citations
18.
Baek, Yeon‐Hee, Sang Jun Park, Sohyun Jeong, et al.. (2018). Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015. Clinical Drug Investigation. 38(12). 1179–1188. 9 indexed citations
19.
20.
Kim, Kyu-Beom, et al.. (2018). Signal detection of benzodiazepine use and risk of dementia: sequence symmetry analysis using South Korean national healthcare database. International Journal of Clinical Pharmacy. 40(6). 1568–1576. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leila Chebane Breakdown of academic impact, for papers by María Sáinz-Gil Breakdown of academic impact, for papers by Li‐Na Kuo Breakdown of academic impact, for papers by Jennifer Corny Breakdown of academic impact, for papers by Justine Bénevent Breakdown of academic impact, for papers by William Wang Breakdown of academic impact, for papers by Fanny Rocher Breakdown of academic impact, for papers by Mê‐Linh Lê Breakdown of academic impact, for papers by Ha‐Lim Jeon Breakdown of academic impact, for papers by H. Karl Greenblatt
Rankless by CCL
2026